SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-000510
Filing Date
2022-01-06
Accepted
2022-01-06 09:01:19
Documents
15
Period of Report
2021-12-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8k.htm   iXBRL 8-K 48526
2 ex10-1.htm EX-10.1 12602
3 ex99-1.htm EX-99.1 10681
  Complete submission text file 0001493152-22-000510.txt   291964

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE mbii-20211230.xsd EX-101.SCH 3277
5 XBRL DEFINITION FILE mbii-20211230_def.xml EX-101.DEF 26450
6 XBRL LABEL FILE mbii-20211230_lab.xml EX-101.LAB 36200
7 XBRL PRESENTATION FILE mbii-20211230_pre.xml EX-101.PRE 25108
9 EXTRACTED XBRL INSTANCE DOCUMENT form8k_htm.xml XML 4578
Mailing Address 1540 DREW AVENUE DAVIS CA 95618
Business Address 1540 DREW AVENUE DAVIS CA 95618 530-750-2800
MARRONE BIO INNOVATIONS INC (Filer) CIK: 0001441693 (see all company filings)

IRS No.: 205137161 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36030 | Film No.: 22513742
SIC: 2870 Agricultural Chemicals